U.K. firm supplies Chinese MR makers

Article

Resonance Instruments has struck an agreement that puts the Witney, U.K., company in a position to supply 95% of the MR control consoles being integrated by Chinese manufacturers. The agreement with Shenzhen AnKe High Technology follows similar

Resonance Instruments has struck an agreement that puts the Witney, U.K., company in a position to supply 95% of the MR control consoles being integrated by Chinese manufacturers. The agreement with Shenzhen AnKe High Technology follows similar agreements with Xingaoyi, Wandong Medical, and several smaller manufacturers. Together these agreements will result in Resonance Instruments delivering about 90 of its DRX digital MRI consoles to China in 2003. The units will be used to control permanent magnet MR systems up to 0.35T. Chinese MR manufacturers are competing with imported and locally manufactured systems from GE, Siemens, Hitachi, and other multinational OEMs.

Climbing sales of relatively low cost permanent magnet MR systems in China are being fueled by an expanding healthcare market, economic growth, and the availability of raw materials for magnet manufacturing, according to the U.K. firm. Although Chinese manufacturers can produce their own magnets, gradients, software, and patient handling equipment, they are not yet capable of manufacturing control consoles or radio-frequency and gradient amplifiers to the required specifications.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.